METHODS
After obtaining IRB approval, patients due for cancer treatment or surveillance between January 1, 2020 and June 30, 2020 were identified using the electronic medical record (EMR). Deceased patients were excluded. A brief electronic survey (Appendix 1) was developed, and an introductory letter containing the link was distributed via mail and at clinic visits. Anonymous responses were voluntarily collected between July and December 2020.
Results were analyzed using descriptive statistics and comparisons of patient distress using demographics, clinical characteristics, and psychosocial factors. For independent predictors that were two-level categorical variables, Mann-Whitney U-test or student t-test was used. For the independent predictors that were more than two-level categorical variables, Kruskal-Wallis test or one-way ANOVA were used. When the independent predictors were continuous variables, Pearson correlation or Spearman correlation were used. All statistical analysis was completed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).